Advantage Investment Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Advantage Investment Management’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-640	Closed	-$3K	–	1103
2017 Q3	$3K	Hold	640	–	–	﹤0.01%	918
2017 Q2	$3K	Hold	640	–	–	﹤0.01%	931
2017 Q1	$4K	Hold	640	–	–	﹤0.01%	841
2016 Q4	$6K	Hold	640	–	–	﹤0.01%	730
2016 Q3	$6K	Hold	640	–	–	﹤0.01%	715
2016 Q2	$9K	Buy	640 +240	+60%	+$3.74K	﹤0.01%	616
2016 Q1	$6K	Hold	400	–	–	﹤0.01%	664
2015 Q4	$8K	Hold	400	–	–	﹤0.01%	613
2015 Q3	$5K	Hold	400	–	–	﹤0.01%	667
2015 Q2	$6K	Hold	400	–	–	﹤0.01%	678
2015 Q1	$8K	Buy	+400	New	+$8.94K	﹤0.01%	636

Other funds holding AGTC

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

MERSOM

Municipal Employees' Retirement System of Michigan Lansing, Michigan $8.81B AUM 10.88% 1-Year Est. Return

Advantage Investment Management's AGTC Position: Q4 2017 in Review

Advantage Investment Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2017, closing a stake of 640 shares — an estimated $3K sold.

Advantage Investment Management first reported a position in AGTC in Q1 2015 and held it in 11 quarters. The position peaked at $9K in Q2 2016. 62 funds tracked by Wall St. Rank hold AGTC as of Q4 2017.

Advantage Investment Management reported no remaining Applied Genetic Technologies Corporation position as of Q4 2017 after selling out during the quarter.
Advantage Investment Management sold 640 Applied Genetic Technologies Corporation shares in Q4 2017, an estimated $3K.
Advantage Investment Management first reported a position in Applied Genetic Technologies Corporation in Q1 2015 and held it in 11 quarters.
Advantage Investment Management's Applied Genetic Technologies Corporation position peaked at $9K in Q2 2016.
62 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2017.

Based on Advantage Investment Management's 13F filing for Q4 2017, filed 12 Feb 2018.